NCT/Study#
N/A /
2017-0341
Outcomes of Patients with Relapsed/Refractory Hodgkin Lymphoma Treated with PD-1 Inhibitors Outside of Clinical Trials
DISEASE GROUP:
current phase:
STUDY STATUS:
Location:
For More information:
